Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Total Current Liabilities (2017 - 2025)

Bioceres Crop Solutions' Total Current Liabilities history spans 7 years, with the latest figure at $338.0 million for Q2 2025.

  • For Q2 2025, Total Current Liabilities rose 2.57% year-over-year to $338.0 million; the TTM value through Jun 2025 reached $338.0 million, up 2.57%, while the annual FY2025 figure was $338.0 million, 2.57% up from the prior year.
  • Total Current Liabilities for Q2 2025 was $338.0 million at Bioceres Crop Solutions, up from $329.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $338.0 million in Q2 2025 and bottomed at $168.0 million in Q2 2021.
  • The 4-year median for Total Current Liabilities is $314.1 million (2023), against an average of $283.6 million.
  • The largest annual shift saw Total Current Liabilities increased 28.66% in 2021 before it increased 2.57% in 2025.
  • A 4-year view of Total Current Liabilities shows it stood at $168.0 million in 2021, then surged by 77.77% to $298.7 million in 2023, then rose by 10.31% to $329.5 million in 2024, then rose by 2.57% to $338.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Total Current Liabilities are $338.0 million (Q2 2025), $329.5 million (Q2 2024), and $298.7 million (Q2 2023).